In a head-to-head comparison of magnetic resonance and ultrasound-based techniques for assessing the extent of non-alcoholic fatty liver disease, MRI has a clear edge, California researchers have found.
In what the investigators say is a first in the United States, they compared the two modalities’ performances in detecting fibrosis and steatosis in patients with NAFLD confirmed on biopsy.
“We are finding, which we knew, that MR is better than FibroScan [Echosens],” said Rohit